ROPER TECHNOLOGIES INC（ROP）の決算・業績分析
ROPER TECHNOLOGIES INCの2025年有価証券報告書をAI分析。売上高$7.9B(+12.3%)。営業利益$2.2B。Health Care。
目次
ROPER TECHNOLOGIES INCの2025年度 業績サマリー
ROPER TECHNOLOGIES INC（証券コード: ROP）の2025年度決算・業績分析。売上高は$7.9B（前年比+12.3%）。営業利益は$2.2B（前年比+11.9%）。純利益は$1.5B（前年比-0.8%）。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。
ROPER TECHNOLOGIES INCの2024年度 注目ポイント
※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。
- Net income surged to $4.5B (+294.3% YoY) with a net margin of 84.6% (XBRL)
- Revenue reached $5.4B (+11.1% YoY) driven by acquisitions and operational improvements (XBRL)
- Operating income grew 22.8% YoY to $1.5B with a 28.4% operating margin (XBRL)
- Free cash flow of $1.9B despite a current ratio of 0.50x indicating liquidity constraints (XBRL)
- Net debt of $5.6B (2.6x EBITDA) with long-term debt at $5.8B (XBRL)
ROPER TECHNOLOGIES INCの売上高変化の要因
- •Total revenue of $5.4B (+11.1% YoY) reflects growth from acquisitions and operational improvements (XBRL). Historical time series shows revenue increased from $4.8B in FY2023 to $6.2B projected for FY2025 (XBRL). While segment-specific revenue figures are not disclosed, the company's growth strategy emphasizes acquiring high-value software businesses and divesting non-core operations (10-K).
ROPER TECHNOLOGIES INCの営業利益変化の要因
- •Gross profit of $3.8B (69.9% margin) and operating income of $1.5B (28.4% margin) show strong efficiency (XBRL). Net income surged to $4.5B (+294.3% YoY) with a net margin of 84.6% (XBRL). Operating income growth of 22.8% YoY may be attributed to divestitures of non-core businesses and improved operational performance (XBRL).
ROPER TECHNOLOGIES INCの事業リスクと対応
Acquisition integration risks: Failure to complete or integrate acquisitions could harm growth and financial performance (10-K)
Technology protection risks: Unauthorized use of proprietary technology may reduce competitive advantage (10-K)
IT system reliance: Disruptions to third-party platforms (e.g., AWS) could impair operations and data security (10-K)
Cybersecurity threats: Attacks or breaches may cause financial loss, reputational damage, and legal liabilities (10-K)
Regulatory approval risks: Acquisitions require antitrust clearances that may not be obtained (10-K)
Market expansion risks: Reliance on successful acquisitions for growth carries integration and performance risks (10-K)
ROPER TECHNOLOGIES INCの今後の見通し・業績予想
ROPER TECHNOLOGIES INCの事業内容
Roper Technologies operates as a diversified technology company specializing in vertical software and technology-enabled products for niche markets (10-K). Its revenue model relies on high-value software sales, services, and solutions across three key segments: Application Software (e.g., Aderant, Frontline), Network Software (e.g., DAT, ConstructConnect), and Technology Enabled Products (e.g., Verathon, Inovonics). The company leverages acquisitions and operational efficiencies to maintain competitive advantages in markets where it is either a market leader or a strong alternative to leaders (10-K).
ROPER TECHNOLOGIES INCのAI業績分析レポート（2024年度）
Roper Technologies Inc (ROP) FY2024 Annual Report Analysis
Highlights
Business Overview
Roper Technologies operates as a diversified technology company specializing in vertical software and technology-enabled products for niche markets (10-K). Its revenue model relies on high-value software sales, services, and solutions across three key segments: Application Software (e.g., Aderant, Frontline), Network Software (e.g., DAT, ConstructConnect), and Technology Enabled Products (e.g., Verathon, Inovonics). The company leverages acquisitions and operational efficiencies to maintain competitive advantages in markets where it is either a market leader or a strong alternative to leaders (10-K).
Revenue Analysis
Total revenue of $5.4B (+11.1% YoY) reflects growth from acquisitions and operational improvements (XBRL). Historical time series shows revenue increased from $4.8B in FY2023 to $6.2B projected for FY2025 (XBRL). While segment-specific revenue figures are not disclosed, the company's growth strategy emphasizes acquiring high-value software businesses and divesting non-core operations (10-K).
Profitability Analysis
Gross profit of $3.8B (69.9% margin) and operating income of $1.5B (28.4% margin) show strong efficiency (XBRL). Net income surged to $4.5B (+294.3% YoY) with a net margin of 84.6% (XBRL). Operating income growth of 22.8% YoY may be attributed to divestitures of non-core businesses and improved operational performance (XBRL).
Balance Sheet Analysis
Equity ratio of 41.0% and debt-to-equity ratio of 0.93x indicate moderate leverage (XBRL). Total assets grew to $28.2B (FY2024) from $23.7B (FY2022) (XBRL). Cash reserves of $214M contrast with net debt of $5.6B (2.6x EBITDA), suggesting potential liquidity challenges despite a current ratio of 0.50x (XBRL).
Cash Flow Analysis
Operating cash flow of $735M was lower than net income of $4.5B (XBRL). Free cash flow reached $1.9B, with $262M in dividends paid (payout ratio: 5.8%) (XBRL). Investing cash flow of $1.2B included major divestitures (e.g., Indicor in 2022) but CapEx figures are not disclosed (10-K).
Working Capital Analysis
Receivables days: 56 days; Inventory days: 27 days (XBRL). Payables days data not available (N/A). Asset turnover of 0.19x suggests underutilization of assets (XBRL).
Risks
Outlook
Management guidance and forward-looking trends are not explicitly detailed in the 10-K text (N/A). Historical trends suggest continued focus on acquisitions and divestitures of non-core businesses as growth drivers (10-K).
Health Careの企業一覧
ROPER TECHNOLOGIES INCと同じ「Health Care」セクターの企業